Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: 061250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,210.00
-54.00 (-4.27%)
Dec 20, 2024, 12:49 PM KST

Hwail Pharmaceutical Co.,Ltd. Revenue

Hwail Pharmaceutical Co.,Ltd. had revenue of 27.82B KRW in the quarter ending March 31, 2017, a decrease of -11.58%. This brings the company's revenue in the last twelve months to 107.87B, down -4.84% year-over-year. In the year 2016, Hwail Pharmaceutical Co.,Ltd. had annual revenue of 111.52B with 5.08% growth.

Revenue (ttm)
107.87B
Revenue Growth
-4.84%
P/S Ratio
0.46
Revenue / Employee
829.81M
Employees
130
Market Cap
99.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2016111.52B5.39B5.08%
Dec 31, 2015106.13B10.03B10.43%
Dec 31, 201496.10B1.94B2.06%
Dec 31, 201394.17B2.33B2.54%
Dec 31, 201291.83B13.74B17.59%
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition